Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan and Linagliptin Interaction Study in Healthy Males
NCT03250052Phase 1Completed
- Sponsor
- Boryung
- Start
- Aug 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fimasartan and linagliptin in hypertension (HTN) and type 2 diabetes mellitus (T2DM), sponsored by Boryung. Started Aug 2017; status: completed.
02
Drugs
fimasartanlinagliptin
03
Conditions
hypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03250052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03250052.